Low Functional health literacy is a problem affecting 90 million residents of the United States. Among the 90 million, 36% are adults who have “below basic” health literacy skills. Assessing health literacy is important in improving health behaviors, health outcomes, and perceived communication barriers related to health. The Patient Protection and Affordable Care Act enacted in 2010 brought about changes that demand a more coordinated approach to manage health care services. This research focused on the efforts being made to promote health literacy at Medicaid health homes such as Greater Buffalo United Accountable Healthcare Network (GBUAHN). This research consisted of observation of Patient Health Navigator interactions with patients in order to identify best practices of health literacy initiatives within GBUAHN. Results suggest best practices include promoting and establishing relationship to effectively enhance patients understanding of all their healthcare needs. This study suggests that GBUAHN should continue making use of recommendations related health literacy promotion while exploring areas of improvement as noted on scorecard. Patient Health Navigators are engaging patient in manner that will establish adherence within patients.
Low Functional health literacy is a problem affecting 90 million residents of the United States. Among the 90 million, 36% are adults who have “below basic” health literacy skills. Assessing health literacy is important in improving health behaviors, health outcomes, and perceived communication barriers related to health. The Patient Protection and Affordable Care Act enacted in 2010 brought about changes that demand a more coordinated approach to manage health care services. This research focused on the efforts being made to promote health literacy at Medicaid health homes such as Greater Buffalo United Accountable Healthcare Network (GBUAHN). This research consisted of observation of Patient Health Navigator interactions with patients in order to identify best practices of health literacy initiatives within GBUAHN. Results suggest best practices include promoting and establishing relationship to effectively enhance patients understanding of all their healthcare needs. This study suggests that GBUAHN should continue making use of recommendations related health literacy promotion while exploring areas of improvement as noted on scorecard. Patient Health Navigators are engaging patient in manner that will establish adherence within patients.
Epidemiology is the study and analysis of the patterns, causes, and effects of health, disease & production conditions in defined populations, in terms of space and temporality.
Global Journal of Infectious Diseases and Clinical Research is an international peer-reviewed journal founded by a network of experts across the globe recognized as the International Infectiologists Network. The mission of GJIDCR is to promote and publish infectious diseases research in areas of basic sciences, clinical medicine and public health.
GJIDCR encourages research, education and dissemination of knowledge in the field of Infectious Diseases across the world thus promoting translational research by striking a synergy between basic science, clinical medicine and public health. The Journal intends to bring together scientists and academicians in Infectious Diseases to promote translational synergy between Laboratory Science, Clinical Medicine and Public Health. The Journal invites Original Articles, Clinical Investigations, Epidemiological Analysis, Data Protocols, Case Reports, Clinical Photographs, review articles and special commentaries. Students, Residents, Academicians, Public Health experts and scientists are all encouraged to be a part of this initiative by contributing, reviewing and promoting scientific works and science.
As per John M. Last (1988) Epidemiology is the study of the distribution and determinants of health related states or events in specified populations, and the application of this study to the control of health problems.
Introduction to Epidemiology
1. Define epidemiology
2. Describe the history of epidemiology
3. Describe aims and components of
epidemiology
4. Discuss on the uses of epidemiology
Epidemiology is the study and analysis of the patterns, causes, and effects of health, disease & production conditions in defined populations, in terms of space and temporality.
Global Journal of Infectious Diseases and Clinical Research is an international peer-reviewed journal founded by a network of experts across the globe recognized as the International Infectiologists Network. The mission of GJIDCR is to promote and publish infectious diseases research in areas of basic sciences, clinical medicine and public health.
GJIDCR encourages research, education and dissemination of knowledge in the field of Infectious Diseases across the world thus promoting translational research by striking a synergy between basic science, clinical medicine and public health. The Journal intends to bring together scientists and academicians in Infectious Diseases to promote translational synergy between Laboratory Science, Clinical Medicine and Public Health. The Journal invites Original Articles, Clinical Investigations, Epidemiological Analysis, Data Protocols, Case Reports, Clinical Photographs, review articles and special commentaries. Students, Residents, Academicians, Public Health experts and scientists are all encouraged to be a part of this initiative by contributing, reviewing and promoting scientific works and science.
As per John M. Last (1988) Epidemiology is the study of the distribution and determinants of health related states or events in specified populations, and the application of this study to the control of health problems.
Introduction to Epidemiology
1. Define epidemiology
2. Describe the history of epidemiology
3. Describe aims and components of
epidemiology
4. Discuss on the uses of epidemiology
CHAPTER 1 ITRODUCTION TO EPIDEMIOLOGICAL METHODS.pptxjohnsniky
Technique:
The needle is held with the needle holder and it should enter the tissues at right angles and be no less than 2-3mm from the incision.
The needle is then carried through the tissue where it follows the needle’s curvature.
Sutures of any type that are placed in the interdental papilae should enter and exit the tissue at a point located below the imaginary line that forms the base of the triangle of the interdental papilla.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
4. EPIDEMIOLOGY
‘I KEEP SIX HONEST SERVING MEN,THEY
TAUGHT ME ALL I KNOW. THEIR NAMES
ARE WHAT , WHY, WHEN, HOW, WHERE
AND WHO’
EPIDEMIOLOGY IS A BASIC SCIENCE
IT IS A STUDY OF DISEASE
DISTRIBUTION, CAUSATION,PREVENTION
AS WELL AS HEALTH AND HEALTH
RELATED EVENTS OCCURING IN HUMAN
POPULATION
5. HISTORY
‘FORBIDDEN FRUIT’
( EPI = AMONG; DEMOS=PEOPLE,
LOGOS =
STUDY) 3RD
CENTURY B.C.
1850 EPIDEMILOGICAL SOCIETY –
LONDON EARL OF
SHAFTESBURY
U.S. - WINSLOW AND SEDGWICK 1920
U.S. - W.H. FROST 1St
PROF. 1927
U.K. - MJ. GREEN WOOD 1St
6. DEFINATIONS
1) THAT BRANCH OF MEDICAL SCIENCE
WHICH TREATS OF EPIDEMICS (PARKIN,
1873)
2) THE SCIENCE OF THE MASS
PHENOMENA OF INFECTIOUS
DISEASES (FROST, 1927)
3) THE STUDY OF DIESEASE, AND
DISEASE, AS A MASS PHENOMENON
(GREENWOOD, 1934)
4) THE STUDY OF DISTRIBUTION AND
DETERMINANTS OF DISEASE
FREQUENCY IN MAN (MAC MAHON,
7. JOHN M. LAST 1988
“ THE STUDY OF THE DISTRUBUTION
AND DETERMINANTS OF HEALTH
RELATED STATES OR EVENTS IN
SPECIFIED POPULATIONS, AND THE
APPLICATION OF THIS STUDY TO
THE CONTROL OF HEALTH
PROBLEMS”
9. AIMS OF
EPIDEMIOLOGYInternational Epidemiological Association (IEA)
a) To describe the distribution & magnitude of
health and disease problems in human
population.
b) To identify etiological factors (risk factors) in
the pathogenesis of disease &
c) To provide the data essential to the
planning, implementation & evaluation of
services for the prevention, control &
treatment of disease & to the setting up of
the priorities among those services.
10. BASIC MEASURAMENTS
IN EPIDEMIOLOGY
a) Measurement of mortality
b) Measurement of morbidity
c) Measurement of disability
d) Measurement of natality
e) Measurement of the presence, absence or
distribution of the characteristics or
attributes of the disease
f) Measurement of medical needs, health care
facilities, utilization of health services &
other health-related events
11. g) Measurement of presence, absence or
distribution of the environmental and
other factors suspected of causing the
disease.
h) Measurement of demographic
variables.
12. AIMS OF
EPIDEMIOLOGY
a) TO DESCRIBE THE DISTRIBUTION &
MAGNITUDE OF HEALTH & DIS.
b) TO IDENTIFY RISK FACTORS
c) TO PROVIDE DATA ESENTIAL TO THE
PLANNING IMPLEMENTATION AND
EVALUATION OF SERVICES FOR PREV.,
CONTROL AND T/T OF DISEASE.
EPIDEMIOLOGY AND CLINICAL MEDICINE
EPIDEMIOLOGICAL APPROACH
a) ASKING QUESTIONS
b) MAKING COMPARISON
13. USES OF
EPIDEMIOLOGY
EPIDEMIOLOGY : ( WORKING DEFINATION)
‘A means of learning or asking questions…
and getting answers that lead to further
questions’
Epidemiology helps in understanding the
strengths & weaknesses of clinical evidence,
such as reports of research, gives intellectual
satisfaction & confidence.
It can increase efficiency in acquiring sound
information
It provides sounder alternatives for conviction,
rhetoric, seniority or speciality of proponent.
14. The investigators are on a more equal
footing, all depending mainly on the
interpretation of the same set of strong
studies.
It gives a perspective on the extent to
which efforts, relative to other factors,
such as biology of the disease & the
physical & social environment,
determines health outcomes, so that
they can know what they can & cannot
change. ( they – clinicians)
15. 1) To study historically the rise & of disease in
the population.
Winston Churchill : “ The farther back you
look, the further forward you can see”
2) Community Diagnosis
( Epidemiology-diagnostic tool – Comm. Med.
)
3) Planning & Evaluation
4) Evaluation of individual risks & chances
5) Syndrome identification
6) Completing the natural history of disease.
7) Searching for causes & risk factors.